Difference between revisions of "Section 3: Conclusions and priorities for future research (from DOI: 10.1016/j.jcv.2020.104372) (Q10722)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: named entity (P78): interleukin 6 (gene) (Q10908), #quickstatements; #temporary_batch_1592942374138)
(‎Added link to [sliswiki]: Section 3: Conclusions and priorities for future research (from DOI: 10.1016/j.jcv.2020.104372), #quickstatements; #temporary_batch_1593012134338)
 
(5 intermediate revisions by the same user not shown)
Property / named entity
 +
Property / named entity: Aicardi-Goutieres syndrome (disease - MeSH supplementary concept) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Human (species) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: COVID-19 (disease - MeSH supplementary concept) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: 2019 novel coronavirus (species) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Infections (disease - MeSH descriptor) / rank
 +
Normal rank
Property / Collection or Dataset of Origin
 +
Property / Collection or Dataset of Origin: Pubtator Central BioC-JSON formatted article files / rank
 +
Normal rank
links / sliswiki / namelinks / sliswiki / name
 +

Latest revision as of 15:22, 24 June 2020

Publication: "SARS-CoV-2: Is it the newest spark in the TORCH?"published as J. Clin. Virol.; 2020 Apr 14 ; 127 104372; DOI: 10.1016/j.jcv.2020.104372
Language Label Description Also known as
English
Section 3: Conclusions and priorities for future research (from DOI: 10.1016/j.jcv.2020.104372)
Publication: "SARS-CoV-2: Is it the newest spark in the TORCH?"published as J. Clin. Virol.; 2020 Apr 14 ; 127 104372; DOI: 10.1016/j.jcv.2020.104372

    Statements

    0 references